We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$5.72M
Cap. Flow
-$3.3M
Cap. Flow %
-1.8%
Top 10 Hldgs %
49.88%
Holding
105
New
16
Increased
25
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$1.54M
2
AMD icon
Advanced Micro Devices
AMD
+$1.11M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.08M
4
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$773K
5
XNCR icon
Xencor
XNCR
+$712K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.12M
2
ARGX icon
argenx
ARGX
+$1.81M
3
JNJ icon
Johnson & Johnson
JNJ
+$761K
4
VIR icon
Vir Biotechnology
VIR
+$642K
5
PANW icon
Palo Alto Networks
PANW
+$639K

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 15.1%
3 Communication Services 6.79%
4 Consumer Discretionary 3.39%
5 Financials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDX icon
76
VanEck Gold Miners ETF
GDX
$22.7B
$283K 0.15%
10,500
– –
INTC icon
77
CALL
Intel
INTC
$455B
$267K 0.15%
+7,500
New +$261K
ALT icon
78
CALL
Altimmune
ALT
$552M
$257K 0.14%
99,000
-35,000
-26% -$100K
JNJ icon
79
Johnson & Johnson
JNJ
$618B
$234K 0.13%
1,500
-4,613
-75% -$761K
BMY icon
80
PUT
Bristol-Myers Squibb
BMY
$133B
$232K 0.13%
+4,000
New +$245K
VRDN icon
81
Viridian Therapeutics
VRDN
$2.09B
$207K 0.11%
13,500
-5,500
-29% -$105K
AIRT icon
82
Air T
AIRT
$75.5M
$204K 0.11%
9,135
– –
IMGN
83
DELISTED
Immunogen Inc
IMGN
$204K 0.11%
12,850
+2,500
+24% +$41.6K
PARA
84
DELISTED
Paramount Global Class B
PARA
$161K 0.09%
12,500
– –
WOLF icon
85
PUT
Wolfspeed
WOLF
$1.23B
$152K 0.08%
+4,000
New +$209K
OVID icon
86
Ovid Therapeutics
OVID
$414M
$117K 0.06%
30,430
-34,334
-53% -$123K
UNG icon
87
United States Natural Gas Fund
UNG
$456M
$102K 0.06%
3,750
– –
LCTX icon
88
Lineage Cell Therapeutics
LCTX
$269M
$97.6K 0.05%
82,751
+67,751
+452% +$92.2K
VIR icon
89
Vir Biotechnology
VIR
$1.46B
$93.7K 0.05%
10,000
-45,000
-82% -$642K
IMPL
90
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$76.8K 0.04%
178,500
-125,105
-41% -$120K
MU icon
91
PUT
Micron Technology
MU
$930B
$68K 0.04%
1,000
-10,500
-91% -$703K
TBHC
92
DELISTED
The Brand House Collective
TBHC
$60.6K 0.03%
35,235
+8,000
+29% +$20.9K
EQ icon
93
Equillium
EQ
$139M
$51.7K 0.03%
69,871
-41,752
-37% -$33.5K
AMRN
94
Amarin Corp
AMRN
$298M
$13K 0.01%
705
-545
-44% -$11.8K
AMGN icon
95
CALL
Amgen
AMGN
$208B
– –
-4,000
Closed -$888K
BUR icon
96
PUT
Burford Capital
BUR
$903M
– –
-2,000
Closed -$24.4K
DOCU
97
CALL
DocuSign
DOCU
$10.5B
– –
-7,500
Closed -$383K
EOG icon
98
EOG Resources
EOG
$79.2B
– –
-4,550
Closed -$521K
LFCR icon
99
CALL
Lifecore Biomedical
LFCR
$166M
– –
-3,000
Closed -$29K
PANW icon
100
Palo Alto Networks
PANW
$270B
– –
-5,000
Closed -$639K
1 2 3
4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, DCF Advisers held 105 positions worth $184M, down 3% from $189M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers's Q3 2023 filing shows 16 new, 25 increased, 26 reduced and 9 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K. The largest sale was Amgen, an estimated $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K.
  • DCF Advisers added most to iShares Russell 2000 ETF in Q3 2023, an estimated $1.54M increase.
  • DCF Advisers's biggest Q3 2023 reduction was Amgen, cutting an estimated $2.12M.
  • DCF Advisers fully exited Palo Alto Networks in Q3 2023, selling an estimated $639K.
  • DCF Advisers's ten largest holdings make up 50% of its $184M portfolio in Q3 2023.
  • DCF Advisers opened 16 new positions and closed 9 in Q3 2023.
  • DCF Advisers's portfolio value fell 3% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.